CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release…

Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules

Read the official FDA notice

Published
10 Dec 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical Inc., Berkeley Heights, NJ 07922 NDC 51991-748-10.

Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Manufactured for : Quallient Pharmaceuticals Health, LLC, Grand Cayman, Cayman Islands, NDC 82009-032-10.

Brand / company
Breckenridge Pharmaceutical, Inc.
Codes / lots
Lot #: 240534C, Exp. Date 01/2027; 240977C, Exp. Date 04/2027. | Lot #: 240947C, 240962C, Exp. Date 04/2027
Distribution
Nationwide within the United States
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 10 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.